QV
Insider
Quan Anh Vu
Chief Financial OfficerQuan Anh Vu (Chief Financial Officer) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in Monopar Therapeutics Inc. (MNPR). Across 1 priced purchase filing, the average 21-session return was -0.7% from execution and -0.6% from disclosure (delay-adjusted; derived). The largest single filing was $105K of MNPR (1,500 sh × $69.95, as filed), executed Dec 26 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
-0.7%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
-0.6%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
3d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$105K
shares × price, as filed
Last traded
Dec 26 2025
Filed Dec 29 2025
Median ADV $24.7M across their filed names
Open performance→Volume by month
Buys $105K
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
MNPRRecent filings
MNPRPURCHASE
Monopar Therapeutics Inc.
View filing →
$105K1,500 sh × $69.95
Exec Dec 26 2025
Filed Dec 29 2025 · 12:15 PM ET